Thienopyridine
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
740 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Coronary artery disease | D003324 | — | I25.1 | 7 | 19 | 28 | 112 | 25 | 185 |
| Acute coronary syndrome | D054058 | EFO_0005672 | — | 8 | 14 | 29 | 45 | 15 | 109 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 5 | 18 | 39 | 8 | 68 |
| Coronary disease | D003327 | — | — | — | 7 | 6 | 41 | 9 | 60 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 8 | 7 | 38 | 7 | 58 |
| Ischemic stroke | D000083242 | — | — | 2 | 7 | 24 | 16 | 12 | 57 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 8 | 24 | 16 | 12 | 55 |
| Healthy volunteers/patients | — | — | — | 40 | 1 | — | 5 | 2 | 48 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | 9 | 24 | 3 | 36 |
| Percutaneous coronary intervention | D062645 | — | — | 1 | 5 | 8 | 15 | 8 | 35 |
Show 99 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cognitive dysfunction | D060825 | — | G31.84 | — | 2 | 1 | — | 2 | 4 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 2 | 1 | — | — | 3 |
| Thromboembolism | D013923 | — | — | — | 2 | 1 | — | 1 | 3 |
| Congenital heart defects | D006330 | — | Q24.9 | — | 1 | 2 | — | — | 3 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | 1 | 1 | — | — | 2 |
| Cerebral hemorrhage | D002543 | — | — | — | 1 | 1 | — | — | 2 |
| Recurrence | D012008 | — | — | — | 1 | 2 | — | — | 2 |
| Heart valve diseases | D006349 | EFO_0009551 | I08 | — | — | 1 | — | 1 | 2 |
| Coronary artery bypass | D001026 | EFO_0003776 | — | — | — | 2 | — | — | 2 |
| Vertebral artery dissection | D020217 | — | I77.74 | — | — | 1 | — | 1 | 2 |
Show 19 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Head and neck neoplasms | D006258 | — | — | 1 | 1 | — | — | — | 2 |
| Hiv | D006678 | — | O98.7 | 1 | 1 | — | — | — | 2 |
| Blood platelet disorders | D001791 | — | — | — | 1 | — | — | 1 | 2 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | 1 | — | — | — | 1 |
| Respiratory insufficiency | D012131 | — | J96.9 | — | 1 | — | — | — | 1 |
| Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | 1 | — | — | — | 1 |
| Cognition disorders | D003072 | — | — | — | 1 | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | — | 1 | — | — | — | 1 |
| Obstructive lung diseases | D008173 | — | — | — | 1 | — | — | — | 1 |
Show 13 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | — | 2 |
| Hemostasis | D006487 | — | — | 2 | — | — | — | — | 2 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | — | — | — | 1 | 2 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | 1 | — | — | — | — | 1 |
| Crush injuries | D000071576 | — | T14.8 | 1 | — | — | — | — | 1 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 1 | — | — | — | — | 1 |
| Hemolytic anemia | D000743 | — | D55-D59 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Surgical blood loss | D016063 | — | — | — | — | — | — | 2 | 2 |
| Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | — | — | 2 | 2 |
| Dyspnea | D004417 | — | R06.0 | — | — | — | — | 2 | 2 |
| Asymptomatic diseases | D058070 | — | — | — | — | — | — | 2 | 2 |
| Cerebrovascular disorders | D002561 | EFO_0003763 | I60-I69 | — | — | — | — | 2 | 2 |
| Coronary occlusion | D054059 | — | I21 | — | — | — | — | 1 | 1 |
| Cerebral amyloid angiopathy | D016657 | EFO_0006790 | I68.0 | — | — | — | — | 1 | 1 |
| Familial cerebral amyloid angiopathy | D028243 | — | — | — | — | — | — | 1 | 1 |
| Hyperuricemia | D033461 | — | — | — | — | — | — | 1 | 1 |
| Colonic polyps | D003111 | — | K63.5 | — | — | — | — | 1 | 1 |
Show 31 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
14 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use